(Q37172696)

18 August 2017

1 reference

title

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders (English)

1 reference

18 August 2017

8

Rochelle Caplan

1 reference

18 August 2017

12

Joan Austin

1 reference

18 August 2017

4

Frank G Gilliam

1 reference

18 August 2017

2

Alan B Ettinger

1 reference

18 August 2017

John J Barry

1

1 reference

18 August 2017

Peggy Friel

3

1 reference

18 August 2017

Cynthia L Harden

5

1 reference

18 August 2017

Bruce Hermann

6

1 reference

18 August 2017

Andres M Kanner

7

1 reference

18 August 2017

Sigita Plioplys

9

1 reference

18 August 2017

Jay Salpekar

10

1 reference

18 August 2017

David Dunn

11

1 reference

18 August 2017

Jana Jones

13

1 reference

18 August 2017

Advisory Group of the Epilepsy Foundation as part of its Mood Disorder

14

1 reference

18 August 2017

publication date

23 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

13 Suppl 1

1 reference

18 August 2017

page(s)

S1-29

1 reference

Mood disorders and medical illness: a major public health problem

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Burden of disease--implications for future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Clinical and health services relationships between major depression, depressive symptoms, and general medical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The Use of Sertraline in Patients with Epilepsy: Is It Safe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Symptoms of depression and anxiety in pediatric epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and anxiety in epilepsy: the association with demographic and seizure-related variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and comorbidity in community-based patients with epilepsy or asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Treatment of depressive disorders in epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychiatric comorbidity in children with new onset epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

An incident case-referent study of epileptic seizures in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Major depression is a risk factor for seizures in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and suicide attempt as risk factors for incident unprovoked seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Patient-validated content of epilepsy-specific quality-of-life measurement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The influence of comorbid depression on quality of life for people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Predictors of pharmacoresistant epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Epilepsy and risk of suicide: a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in epilepsy. Significance and phenomenology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Collaborative Group for Epidemiology of Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychologic and behavioral disturbance among epileptic children treated with barbiturate anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Vigabatrin and behaviour disturbance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Neuropsychiatric side effects related to treatment with felbamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Rapid detection of major depression in epilepsy: a multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Screening for major depression in epilepsy with common self-report depression inventories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Cerebral metabolism and depression in patients with complex partial seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in temporal lobe epilepsy surgery patients: an FDG-PET study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Chronic epilepsy and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Neuropsychological and behavioral effects of antiepilepsy drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Impact of depressed mood on neuropsychological status in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Are negative mood states associated with cognitive function in newly diagnosed patients with epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Differentiation of executive and attention impairments in affective illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Epilepsy and poor memory: who complains and what do they mean?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Memory Complaints in Medically Refractory Epilepsy: Relationship to Epilepsy-Related Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The perception of memory failures in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Memory complaints in epilepsy: correlations with cognitive performance and neuroticism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

[Knowledge and attitude of the general public regarding symptoms, etiology and possible treatments of depressive illnesses]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Antidepressants and seizures: emphasis on newer agents and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Seizure secondary to citalopram overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Seizures after buproprion overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Anticonvulsant effect of fluoxetine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychotropic effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The genetically epilepsy-prone rat (GEPR)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Status epilepticus associated with the combination of valproic acid and clomipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Bupropion-methylphenidate combination and grand mal seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Seizures associated with maprotiline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Seizures associated with high maprotiline serum concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychotropic effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Placebo-controlled study of gabapentin treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Topiramate and psychiatric adverse events in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Toxic serotonin syndrome after fluoxetine plus carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Combination therapy of lamotrigine and escitalopram may cause myoclonus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Sertraline-induced hypomania: a genuine side-effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Emergent suicidality in a clinical psychotherapy trial for adolescent depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Sexual dysfunction associated with antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Removing barriers to care among persons with psychiatric symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and anxiety disorders in pediatric epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Symptoms of depression in adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Anxiety in children with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Preventing depression in adolescents with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in children and adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Behavioral disorders in pediatric epilepsy: unmet psychiatric need

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Comorbidity of internalizing disorders in children with oppositional defiant disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Irritability in pediatric mania and other childhood psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Unmet mental health needs in pediatric epilepsy: insights from providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Neuropsychiatric complications of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Factors Associated with Academic Achievement in Children with Controlled Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

7 January 2021

Stress and depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychopathology in children with epilepsy: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Identifying risk factors for maternal depression in families of adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Behavioral issues involving children and adolescents with epilepsy and the impact of their families: recent research data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Academic achievement in children with epilepsy or asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles of demographic, seizure, and psychosocial variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Social competence in pediatric epilepsy: insights into underlying mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Thought disorder: A developmental disability in pediatric epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Reading problems, psychiatric disorders, and functional impairment from mid- to late adolescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Auditory event-related potential indices of increased distractibility in children with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Reading problems and depressed mood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Neurocognitive correlates of anxiety disorders in children: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Issues in parent-child agreement: the case of structured diagnostic interviews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Ten-year review of rating scales. II: Scales for internalizing disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Puberty and depression: the roles of age, pubertal status and pubertal timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A DSM-IV-referenced, adolescent self-report rating scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Diagnosis and measurement of anxiety disorder in adolescents: a review of commonly used instruments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Epidemiology of childhood depressive disorders: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Course and outcome of child and adolescent major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Development and natural history of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Randomized trial of a program to enhance the competencies of children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A randomized field trial of ACINDES: a child-centered training model for children with chronic illnesses (asthma and epilepsy).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Epilepsy familiarity, knowledge, and perceptions of stigma: report from a survey of adolescents in the general population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Stigma in the lives of adolescents with epilepsy: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Teachers' knowledge about epilepsy and attitudes toward students with epilepsy: results of a national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Negative emotions in children with newly diagnosed epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The information needs and understanding of 5-10-year old children with epilepsy, asthma or diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Family predictors of psychopathology in children with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Practice parameter for psychiatric consultation to schools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Childhood depression: pharmacological therapy/treatment (pharmacotherapy of childhood depression).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Suicidality in pediatric patients treated with antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Use of risperidone in children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and epilepsy: how closely related are they?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Is the Psychopathology of Epilepsy Different from That of Nonepileptic Patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression and the risk of neurological disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Residual symptoms after partial remission: an important outcome in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Cognitive-behavioral treatment of depressed affect among epileptics: preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The treatment of depression in patients with epilepsy. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Effect of doxepin on seizure frequency in depressed epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Effect of psychotropic medications on seizure control in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Treatment of Interictal Depression with Citalopram in Patients with Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Citalopram as treatment of depression in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Antidepressant and double antidepressant treatment for the affective disorder of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Common pathogenic mechanisms between depression and epilepsy: an experimental perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Current and future therapeutic opportunities in the comorbidity between the epilepsies and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Diagnosis and treatment of mood disorders in persons with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Use of treatment algorithms for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Use of antidepressant combinations: which, when and why? Results of a Spanish survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The road to recovery from depression--don't drive today with yesterday's map.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Lamotrigine in patients with epilepsy and comorbid depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Depression, locus of control, and the effects of epilepsy surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychopathology in epilepsy and learned helplessness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The impact of chronic epilepsy on the family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Electroconvulsive therapy for epilepsy and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Electroconvulsive therapy (ECT) for intractable depression following epilepsy neurosurgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Electroconvulsive therapy in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A study of the incidence of epilepsy following ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Augmentation and combination strategies for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychoneuroendocrine aspects of temporolimbic epilepsy. Part I. Brain, reproductive steroids, and emotions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychoneuroendocrine aspects of temporolimbic epilepsy. Part II: Epilepsy and reproductive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Psychoneuroendocrine aspects of temporolimbic epilepsy. Part III: Case reports.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Antidepressant effects of augmentative transcranial magnetic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Vagus nerve stimulation therapy summary: five years after FDA approval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The cellular neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Lithium-carbamazepine neurotoxicity and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

The recognition and management of mood disorders as a comorbidity of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Safety of antidepressants in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

Maprotiline-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.04.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2008.04.005

1 reference

18 August 2017

1 reference